NCT03982238View on ClinicalTrials.gov

Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

November 15, 2019

Study Completion Date

December 31, 2019

Conditions
Type 2 Diabetes
Interventions
DRUG

Insulin

Continuous subcutaneous insulin infusion therapy for 1 month

DRUG

Metformin

Continuous subcutaneous insulin infusion plus metformin (at least1000mg/day) for 1 month

DRUG

Dapagliflozin

Continuous subcutaneous insulin infusion plus metformin (10mg/day) for 1 month

Trial Locations (1)

Unknown

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Majianhua

OTHER

NCT03982238 - Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients | Biotech Hunter | Biotech Hunter